Search

everythinglearnresearchcommunity

for

Search:↓

Free fatty acids may increase androgen production, potentially contributing to polycystic ovary syndrome.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Testosterone affects brain behavior in complex and varied ways.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Testosterone replacement is recommended for men with low testosterone levels and symptoms of hypogonadism.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

5α-reductase inhibitors like finasteride may not be effective or safe for transgender individuals, and more research is needed.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Pre-operative hormone treatment for hypospadias surgery might improve outcomes, but more research is needed to confirm.

Testosterone with finasteride improved muscle and bone health in men with spinal cord injury.

Hormonal therapy for transgender individuals carries health risks but is a personal choice.

Hormone treatment before hypospadias surgery can increase penis size and reduce surgery complications.

Hormones, especially testosterone and DHT, are key for penis development and function, and testosterone therapy may help with erectile dysfunction in those with low levels.

New treatments for male hypogonadism are effective and should be personalized.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

The document explains how the male reproductive system works, its role in making testosterone, and how conditions like obesity can disrupt it, leading to low testosterone and fertility issues.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Human hair follicles have a unique metabolism that changes between growth stages and may contribute to baldness.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.